[HLIND] YoY Cumulative Quarter Result on 31-Dec-2022 [#2]

Stock
[HLIND] HONG LEONG INDUSTRIES BHD
Announcement Date
16-Feb-2023
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2023
Quarter
31-Dec-2022 [#2]
Profit Trend
QoQ- 89.8%
YoY- 108.79%
Quarter Report
Latest QR
Upcoming QR
HLIND's Result
HLIND's Financial Summary
View:
Show?
Cumulative Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 1,579,423 1,726,055 1,054,062 1,423,339 1,524,128 1,375,761 1,261,737 3.81%
PBT 314,672 256,833 138,548 249,487 236,282 235,098 235,049 4.98%
Tax -67,033 -53,814 -37,819 -47,669 -48,864 -40,849 -36,026 10.89%
NP 247,639 203,019 100,729 201,818 187,418 194,249 199,023 3.70%
-
NP to SH 190,144 155,414 74,435 150,961 141,451 156,785 164,804 2.41%
-
Tax Rate 21.30% 20.95% 27.30% 19.11% 20.68% 17.38% 15.33% -
Total Cost 1,331,784 1,523,036 953,333 1,221,521 1,336,710 1,181,512 1,062,714 3.83%
-
Net Worth 2,152,035 1,997,233 1,920,861 1,800,566 1,720,681 1,566,550 1,374,095 7.75%
Dividend
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Div 220,237 62,905 53,444 53,419 53,378 47,090 46,422 29.61%
Div Payout % 115.83% 40.48% 71.80% 35.39% 37.74% 30.04% 28.17% -
Equity
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Net Worth 2,152,035 1,997,233 1,920,861 1,800,566 1,720,681 1,566,550 1,374,095 7.75%
NOSH 327,903 327,903 327,903 327,903 327,903 327,903 327,905 -0.00%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 15.68% 11.76% 9.56% 14.18% 12.30% 14.12% 15.77% -
ROE 8.84% 7.78% 3.88% 8.38% 8.22% 10.01% 11.99% -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 502.00 548.78 335.28 452.95 485.40 438.23 407.69 3.52%
EPS 60.44 49.41 23.68 48.04 45.05 49.96 53.21 2.14%
DPS 70.00 20.00 17.00 17.00 17.00 15.00 15.00 29.25%
NAPS 6.84 6.35 6.11 5.73 5.48 4.99 4.44 7.46%
Adjusted Per Share Value based on latest NOSH - 327,903
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
RPS 481.67 526.39 321.46 434.07 464.81 419.56 384.79 3.81%
EPS 57.99 47.40 22.70 46.04 43.14 47.81 50.26 2.41%
DPS 67.17 19.18 16.30 16.29 16.28 14.36 14.16 29.60%
NAPS 6.563 6.0909 5.858 5.4912 5.2475 4.7775 4.1906 7.75%
Price Multiplier on Financial Quarter End Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 -
Price 9.21 9.20 9.18 8.89 10.42 8.50 9.69 -
P/RPS 1.83 1.68 2.74 1.96 2.15 1.94 2.38 -4.28%
P/EPS 15.24 18.62 38.77 18.51 23.13 17.02 18.20 -2.91%
EY 6.56 5.37 2.58 5.40 4.32 5.88 5.50 2.97%
DY 7.60 2.17 1.85 1.91 1.63 1.76 1.55 30.32%
P/NAPS 1.35 1.45 1.50 1.55 1.90 1.70 2.18 -7.67%
Price Multiplier on Announcement Date
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Date 21/02/24 16/02/23 23/02/22 26/02/21 26/02/20 18/02/19 05/02/18 -
Price 9.58 8.95 9.70 8.18 9.40 9.42 9.50 -
P/RPS 1.91 1.63 2.89 1.81 1.94 2.15 2.33 -3.25%
P/EPS 15.85 18.11 40.97 17.03 20.87 18.86 17.84 -1.95%
EY 6.31 5.52 2.44 5.87 4.79 5.30 5.61 1.97%
DY 7.31 2.23 1.75 2.08 1.81 1.59 1.58 29.07%
P/NAPS 1.40 1.41 1.59 1.43 1.72 1.89 2.14 -6.82%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment